Introduction
============

High energy and high fat intake characterizes the diet of numerous Western populations. Particularly, the deleterious role of excessive saturated fatty acid (SFA) intake on the cardiovascular system has been consistently demonstrated. When combined with physical inactivity, these habits contribute to the accumulation of body fat, which generates a pro-inflammatory status. Several lines of evidence support the notion that SFA intake is the main trigger of inflammation in white adipose tissue ([@B01]).

Adipocytes play a major role in energy balance, immune function and homeostasis of glucose and lipid metabolism ([@B02]). Excessive SFA consumption leads to adipocyte hypertrophy and dysfunction, inducing the secretion of inflammatory factors, which results in a status of chronic low-grade inflammation ([@B03]) and is the pathophysiological basis for metabolic and cardiovascular diseases ([@B02]). In addition to SFA, *trans* fatty acid intake is also associated with metabolic disturbances ([@B04]).

Hypertrophic adipocytes and macrophages are responsible for the increased expression of pro-inflammatory genes and secretion of cytokines such as interleukins and tumor necrosis factor alpha (TNF-α). The latter was the first adipocytokine found to be directly associated with insulin resistance ([@B05],[@B06]).

Obesity-induced cytokine secretion (TNF-α, interleukins) promotes an increase in hepatic synthesis of C-reactive protein (CRP), whose concentration has been used to assess the risk of cardiovascular disease as well as type 2 diabetes mellitus. Conversely, adiponectin concentration has been associated with protective cardiometabolic effects ([@B02]). It is possible that the determination of circulating levels of TNF-α, interleukins, CRP, and adiponectin may enhance the knowledge of the pathophysiological events linking SFA consumption and insulin resistance induction. It was previously found that SFA stimulate intracellular insulin signaling via the nuclear factor-κB (NF-κB), negatively influencing the translocation of glucose transporters to the plasma membrane ([@B03]).

In addition to the deleterious impact of dietary SFA on metabolism and the cardiovascular system ([@B04],[@B07]), prospective studies have reported an association of *trans* fatty acid intake with increased risk of type 2 diabetes mellitus ([@B08]). In contrast, diets rich in unsaturated fatty acids - such as the Mediterranean diet - have been shown to have beneficial effects against cardiovascular events ([@B09]). Such evidence elucidating the role of the consumption of different fatty acids in insulin sensitivity is relevant to orient health policies for populations at cardiometabolic risk ([@B01]). Another lifestyle factor of relevance for cardiometabolic homeostasis is physical activity. Inactivity is considered to be a major cardiovascular risk factor, while regular physical activity improves glucose and lipid metabolism ([@B03],[@B04],[@B10],[@B11]).

Since the main causes of mortality are adiposity-related diseases ([@B12]-[@B14]), it is desirable to understand how daily habits influence their pathophysiologic chain. Little data are available concerning the association of fatty acid intake with metabolic disturbances, adjusted for physical activity, mediated by inflammation and insulin resistance, in Brazilian population samples. We hypothesized that, similar to the role of SFA in insulin resistance, *trans* fatty acid intake may also contribute to the deterioration of insulin sensitivity, which may be mediated by proinflammatory markers. Therefore, the objective of the present study was to assess the associations of saturated or *trans* fatty acid intake with insulin resistance.

Material and Methods
====================

This cross-sectional study included individuals at high cardiometabolic risk, selected for an 18-month prevention program of type 2 diabetes mellitus, conducted at the Health Center of the Faculdade de Saúde Pública, Universidade de São Paulo, Brazil. The local Research Ethics Committee approved the research protocol and all participants gave written informed consent. Of 438 individuals screened between 2008 and 2009, 230 were eligible and 183 agreed to participate. Among those who did not agree to participate there was a predominance of men; however, non-participants did not differ from participants in terms of sociodemographic, anthropometric or metabolic variables. Their basal dietary, clinical and laboratory data were analyzed. Inclusion criteria were adults aged 18 to 69 years with prediabetic conditions (impaired glucose tolerance or impaired fasting glycemia) ([@B15]) or with metabolic syndrome without diabetes, defined according to the International Diabetes Federation ([@B16]). Individuals with a medical history of neurological or psychiatric disturbances, thyroid, liver, renal, and infectious diseases were excluded.

Data collection
---------------

Trained staff collected dietary, physical activity and clinical data. Food intake was assessed by means of three 24-h dietary recalls applied on non-consecutive days. The mean energy and macronutrient intakes of each individual were calculated. Physical activity was evaluated using the long version of the international physical activity questionnaire ([@B17]) and reported as minutes per week.

Height was measured using a fixed stadiometer and weight was measured on a Filizola digital scale with the subjects wearing light clothing and no shoes. Body mass index (BMI) was subsequently calculated. Abdominal circumference was measured at the midpoint between the bottom of the rib cage and above the top of the iliac crest during minimal respiration. Percent body fat was estimated with a single-frequency bioimpedance analyzer (RJL Systems Inc., model Quantum II, USA). Tetrapolar placement of electrodes was used and individuals\' weight, height, age and gender were entered into the instrument for analysis with the measured bioelectrical impedance to calculate body composition based on manufacturer equations.

Blood pressure was measured at rest in the sitting position, 3 times at 5-min intervals with an automatic blood pressure device (Omron HEM-712C, Omron Health Care, USA). The average of the last 2 recorded measurements was used for analysis.

Participants were submitted to a 75-g oral glucose tolerance test and venous blood samples were obtained for several determinations. Categories of glucose tolerance were defined according to American Diabetes Association criteria ([@B15]). Plasma glucose and lipoproteins were immediately determined in the local laboratory using routine methods. Aliquots were frozen at -80°C for further determinations of inflammatory markers and hormones. Ultra-sensitive CRP, interleukin-6 (IL-6) and TNF-α were determined by an immunoenzyme chemiluminescent assay (Immulite, Diagnostic Products Corporation, USA). Insulin was determined by an immunometric assay using a quantitative chemiluminescent kit (AutoDelfia, Perkin Elmer Life Sciences Inc., USA) and adiponectin by an enzyme-linked immunosorbent assay (Linco Research, USA). Homeostasis model assessment was used to assess insulin resistance (HOMA-IR) ([@B12]). Insulin resistance was defined using the HOMA-IR cut-off value of 2.71, based on a previous study conducted on a similar Brazilian sample ([@B18]).

Statistical analysis
--------------------

Dietary, physical activity, clinical and inflammatory data are reported as means ± SD or percentages. Nutrient intake is reported in grams and/or percent of total energy intake. Dietary data were adjusted according to the method of Willett and Stampfer ([@B19]) and processed using the Nutrition Data System^®^ software (Minnesota Nutrition Coordinating Center, USA). Normality of variables was tested with the Kolmogorov-Smirnov test and those that were not normally distributed were log-transformed. The Student *t*-test (or a non-parametric equivalent) was used for comparisons between categories. Frequencies were compared by the chi-square test. Pearson\'s coefficient was used to test correlations between variables. In stepwise linear regression analysis, the HOMA-IR index was the dependent variable. Variables showing a P value \<0.20 in univariate analysis were selected for entry into the multiple model. Fatty acid intake was the independent variable of main interest, adjusted for age, gender, BMI, and total physical activity. Inflammatory markers (IL-6, adiponectin and CRP) were included to examine the influence of the inflammatory process on insulin resistance. HOMA-IR, *trans* fatty acid intake, physical activity, and adiponectin concentration were log-transformed.

All analyses were conducted using SPSS version 17.0 for Windows (SPSS Inc., USA). A P value of \<0.05 was considered to be significant.

Results
=======

In the study sample of 183 individuals, 121 (66%) were women, mean age was 55.7 ± 12.3 years and mean HOMA-IR values were 2.50 ± 1.77. Participants were divided into 2 groups according to the cut-off value of HOMA-IR, with 127 individuals allocated to the group without insulin resistance and 56 to the group with insulin resistance (30.6%). As expected, mean HOMA-IR values differed markedly between the groups with and without insulin resistance 4.49 ± 1.88 *vs* 1.62 ± 0.64, P \< 0.001, respectively). Comparisons of mean dietary and clinical data are shown in [Tables 1](#t01){ref-type="table"} and [2](#t02){ref-type="table"}. Groups did not differ in energy or nutrient consumption. Insulinresistant individuals spent less time performing physical activity, had lower body adiposity, but similar blood pressure levels.

Table 1.Dietary, physical activity, and clinical data of individuals stratified according to the presence of insulin resistance (IR).Without IR (N = 127)With IR (N = 56)Intake Energy (kcal)1769.3 ± 644.51909.1 ± 859.1 Carbohydrate[\#](#TFN02t01){ref-type="table-fn"} (g)210.6 ± 32.8213.9 ± 36.9 Protein[\#](#TFN02t01){ref-type="table-fn"} (g)77.6 ± 18.577.4 ± 17.6 Total fat[\#](#TFN02t01){ref-type="table-fn"} (g)60.4 ± 13.059.3 ± 13.6 Saturated fat[\#](#TFN02t01){ref-type="table-fn"} (g)18.8 ± 6.218.3 ± 5.1 Monounsaturated fat[\#](#TFN02t01){ref-type="table-fn"} (g)20.9 ± 5.720.5 ± 5.9 Polyunsaturated fat[\#](#TFN02t01){ref-type="table-fn"} (g)15.4 ± 4.515.6 ± 4.4 Omega 6 fatty acids[\#](#TFN02t01){ref-type="table-fn"} (g)13.60 ± 4.0413.66 ± 3.97 Omega 3 fatty acids[\#](#TFN02t01){ref-type="table-fn"} (g)1.84 ± 0.571.99 ± 0.67 Omega 6/omega 3 ratio7.67 ± 1.527.45 ± 1.15 *Trans* fatty acids[\#](#TFN02t01){ref-type="table-fn"} (g)3.25 ± 2.233.40 ± 2.35 Total fiber[\#](#TFN02t01){ref-type="table-fn"} (g)15.5 ± 7.114.6 ± 5.7 Total sugar[\#](#TFN02t01){ref-type="table-fn"} (g)75.1 ± 25.079.8 ± 27.4 Added sugar[\#](#TFN02t01){ref-type="table-fn"} (g)38.5 ± 21.439.8 ± 22.2Total physical activity (min/week)228.3 ± 239.3138.5 ± 100.2[\*](#TFN03t01){ref-type="table-fn"}Leisure physical activity (min/week)46.1 ± 75.419.9 ± 41.6Body mass index (kg/m^2^)29.5 ± 5.133.9 ± 6.1[\*](#TFN03t01){ref-type="table-fn"}Abdominal circumference (cm)97.9 ± 11.0108.9 ± 13.5[\*](#TFN03t01){ref-type="table-fn"}Fat mass (%)32.8 ± 8.838.2 ± 9.2[\*](#TFN03t01){ref-type="table-fn"}Systolic blood pressure (mmHg)135.5 ± 20.3136.1 ± 17.8Diastolic blood pressure (mmHg)82.2 ± 10.384.0 ± 10.3[^1][^2][^3]

Table 2.Laboratory variables of individuals stratified according to the presence of insulin resistance (IR).Without IR (N = 127)With IR (N = 56)Fasting plasma glucose (mg/dL)96.9 ± 11.3104.5 ± 10.2[\*](#TFN03t01){ref-type="table-fn"}Post-load plasma glucose (mg/dL)115.0 ± 26.9125.8 ± 27.3[\*](#TFN03t01){ref-type="table-fn"}Triglycerides (mg/dL)144.3 ± 60.7165.9 ± 82.7Fasting insulin (µIU/mL)6.89 ± 2.8717.60 ± 7.48[\*](#TFN03t01){ref-type="table-fn"}Total cholesterol (mg/dL)202.1 ± 37.9192.2 ± 50.6HDL cholesterol (mg/dL)43.4 ± 11.539.6 ± 11.9[\*](#TFN03t01){ref-type="table-fn"}LDL cholesterol (mg/dL)129.0 ± 35.2119.2 ± 45.0VLDL cholesterol (mg/dL)28.5 ± 11.332.2 ± 15.0Leukocytes (N/mm^3^)6606 ± 17447065 ± 1745Interleukin-6 (pg/mL)2.77 ± 3.103.79 ± 3.33[\*](#TFN03t01){ref-type="table-fn"}C-reactive protein (mg/dL)0.48 ± 0.520.60 ± 0.59Adiponectin (ng/mL)16.2 ± 15.411.3 ± 6.9[\*](#TFN03t01){ref-type="table-fn"}TNF-α (ng/mL)12.5 ± 6.512.4 ± 7.1[^4][^5]

Mean HDL cholesterol and adiponectin values were lower, and IL-6 concentration was higher, in the insulin-resistant group compared to the group without insulin resistance ([Table 2](#t02){ref-type="table"}). Groups did not differ significantly concerning other laboratory variables.

Significant correlation coefficients were found between habits, anthropometric measurements, biomarkers, and HOMA-IR. Energy intake and abdominal circumference were correlated (r = 0.191, P = 0.010). Energy (r = -0.227; P = 0.002) and omega-6 polyunsaturated fatty acid (r = -0.172, P = 0.020) intakes were inversely correlated with adiponectin concentration. Saturated fat intake was correlated with IL-6 levels (r = 0.172, P = 0.025), leukocyte count (r = 0.153, P = 0.041), and added sugar to CRP (r = 0.210, P = 0.005). Fat mass also showed a correlation with CRP (r = 0.419, P \< 0.001; [Figure 1](#f01){ref-type="fig"}, Panel B).

Figure 1.Correlation of HOMA-IR with total physical activity (*Panel A*), abdominal circumference (*Panel B*), leukocyte count (*Panel C*), and *trans* fatty acid intake (*Panel D*). HOMA-IR = homeostasis model assessment-insulin resistance.

HOMA-IR was correlated with several variables ([Figure 1](#f01){ref-type="fig"}): physical activity (r = -0.168, P = 0.038), *trans* fatty acid intake (r = 0.160, P = 0.030), abdominal circumference (r = 0.430, P \< 0.001), leukocyte count (r = 0.397, P = 0.005), and adiponectin concentrations (r = -0.288, P \< 0.001).

Independent associations with HOMA-IR in multiple linear regression analysis are shown in [Table 3](#t03){ref-type="table"}. The final model revealed that HOMA-IR was independently associated with *trans* fatty acid intake (β = 1.416, P = 0.039) and BMI (β = 0.390, P \< 0.001), and also inversely associated with adiponectin (β = -1.637, P = 0.004), after adjustment for age, gender and physical activity. Inclusion of other nutrients such as saturated fat or added sugar or other inflammatory markers (IL-6 and CRP) in the models did not modify these associations.

Table 3.Final linear regression model for the association with HOMA-IR.β95% confidence intervalP*Trans* fatty acid intake[\#](#TFN02t01){ref-type="table-fn"}1.4161.016 to 1.8200.039Adiponectin[\#](#TFN02t01){ref-type="table-fn"}-1.637-2.203 to -1.1640.004Age0.051-0.002 to 0.0050.510Physical activity[\#](#TFN02t01){ref-type="table-fn"}-1.180-1.426 to 1.1250.325Body mass index0.3900.012 to 0.026\<0.001[^6]

Discussion
==========

The present study contributes to the knowledge about the pathophysiologic relationship between certain dietary habits - particularly fatty acid intake - and insulin resistance. HOMA-IR was used to express insulin resistance and its cut-off value was obtained in a Brazilian sample with similar sociodemographic and clinical characteristics as the present sample ([@B18]). The cut-off of 2.71 does not differ markedly from others previously proposed ([@B20]). Since our study sample had risk factors for type 2 diabetes mellitus, a considerable proportion of insulin-resistant individuals was expected (30.6%). Several findings indicate that this value is adequate to identify insulin resistance; this subset showed higher body adiposity and plasma concentrations of glucose and IL-6, as well as lower concentrations of HDL cholesterol and adiponectin, typical abnormalities found in metabolic syndrome.

The independent association of *trans* fatty acid intake and HOMA-IR was statistically significant in our study, although the clinical relevance of this finding requires further investigation. The deleterious role of saturated and *trans* fatty acids in glucose and lipid metabolism has been consistently demonstrated ([@B03],[@B04],[@B07]). This effect is due at least in part to increased body fatness, since hypertrophic adipocytes and infiltrating macrophages are important sources of cytokines - such as TNF-α and IL-6 - which cause the deterioration of insulin sensitivity. The total fat intake found in our sample (approximately 30% of total energy intake) is comparable to levels reported in other Western populations ([@B21]). In crude analysis, total fat intake was not correlated with body adiposity, although the latter was shown to be associated with inflammatory markers (percent of fat mass with CRP) and insulin resistance (abdominal circumference with HOMA-IR). Interestingly, saturated fat consumption seemed to be correlated with IL-6 and leukocyte count, a fact that was not confirmed after adjustment. The ability of certain nutrients, such as fatty acids, to penetrate through the lipoprotein membrane and to induce gene expression has been clearly demonstrated ([@B07],[@B22]).

This set of findings is coherent with the statement that obesity is a condition involving inflammation and insulin resistance. Evidence from animal models has shown that inflammatory cytokines cause intracellular abnormalities such as activation of IkB kinase (IKK) and c-Jun N-terminal kinase (JNK) and increased serine phosphorylation of insulin receptor substrate 1, which inhibit insulin signaling and glucose transport, generating insulin resistance ([@B23],[@B24]). Our data may suggest that these processes, inflammation and insulin resistance, coexist in the participants of this study. A direct correlation of HOMA-IR with leukocyte count and an inverse correlation of HOMA-IR with adiponectin are consistent with the hypothesis that intracellular inflammatory factors contribute to inducing insulin resistance ([@B03],[@B16]). Low circulating levels of adiponectin have been described within the spectrum of metabolic syndrome ([@B25]). Although associations with pro-inflammatory factors were not supported by our study, the detection of an independent inverse association of HOMA-IR with adiponectin is relevant considering its cardioprotective effect.

Using multiple linear regression, we investigated whether saturated and *trans* fatty acids, independent of their impact on body adiposity, could contribute to the generation of inflammation and the deterioration of insulin sensitivity. In animal models, a high-fat diet induces endoplasmic reticulum stress, which activates IKK and JNK, thereby impairing insulin signaling ([@B24]). The gut microbiota of obese individuals or those consuming a high content of these fatty acids contains a predominance of Gram-negative bacteria rich in lipopolysaccharides (LPS). LPS are recognized by Toll membrane receptors in the circulation (endotoxemia), activating these kinases to generate insulin resistance, as well as NFκB, which result in the expression of inflammatory genes. Similar to LPS, saturated fatty acids are also recognized by membrane receptors triggering proinflammatory signaling pathways ([@B26]).

A strength of the present study was the availability of physical activity data; this practice could introduce a potential confounder in the analysis of the relationship of dietary factors and metabolic abnormalities. Exercise enhances glucose uptake by stimulating glucose transporter type 4 translocation to the plasma membrane, independently of insulin ([@B27]). However, the level of physical activity was not associated with HOMA-IR in the present study. This lack of association may be attributed at least in part to the low frequency of physical activity practiced by our sample. Adjustment for physical activity did not alter the results of HOMA-IR with nutrients obtained from the regression analysis.

The crude analysis seemed to support previous evidence that saturated fatty acid intake could induce a proinflammatory status, but in adjusted analysis only *trans* fatty acids were independently associated with insulin resistance. Considering that foods rich in *trans* fat may have a high sugar content, we tested whether the inclusion of added sugar could be a confounder in our analysis of the association with HOMA-IR. However, added sugar proved not to influence the strength of the association of interest.

Considering the hypothesis that fatty acid intake may impair inulin sensitivity indirectly via the expression of inflammatory genes (TNF-α and interleukins), IL-6 or CRP and adiponectin concentrations were selected for input to the regression model. Adiponectin remained inversely associated with HOMA-IR, a finding consistent with its expected protective effects ([@B02]), but IL-6 or CRP did not. Since inflammatory markers did not modify the association of *trans* fatty acid intake with HOMA-IR, our results did not support the hypothesis that *trans* fatty acids can generate insulin resistance by inducing proinflammatory cytokine expression. These findings conflict with the results of other studies showing that NF-κB is activated by *trans* fatty acid ([@B28]).

Our study has limitations. First, the design is not appropriate to investigate causal relationships and the rate of losses was relatively high. Second, there was a limitation inherent to the tool used for assessing diet; despite extensive use of 24-h food recalls, three recalls may not be sufficiently sensitive to quantify nutrient intake; additionally, insulin resistance develops over the long-term while food recalls reflect recent habits. This aspect may have precluded the detection of the previously reported association of saturated fat intake with insulin resistance ([@B07]).

The finding of an association of *trans* fatty acid intake with HOMA-IR corroborates the assumption that this nutrient could play a role in the generation of insulin resistance, but not necessarily by stimulating inflammatory genes. We speculate that *trans* fatty acids should predominantly influence insulin sensitivity via activation of intracellular kinases, which alter insulin receptor substrates. However, activation of transcription factors for the expression of proinflammatory genes, contributing to reduced glucose uptake, cannot be excluded. Studies with a suitable design and more accurate tools for measuring long-term food consumption are desirable to refine future investigations of these associations.

[^1]: Data are reported as means ± SD.

[^2]: Adjusted according to Willett and Stampfer ([@B19]).

[^3]: P \< 0.05 compared to without IR (Student *t*-test for independent samples).

[^4]: Data are reported as means ± SD. TNF-α = tumor necrosis factor alpha.

[^5]: P \< 0.05 compared to without IR (Student *t*-test for independent samples).

[^6]: Anti-log-transformed values. HOMA-IR = homeostasis model assessment-insulin resistance.
